CN104721276A - Traditional Chinese medicine vinegar for treating hyperlipidemia - Google Patents
Traditional Chinese medicine vinegar for treating hyperlipidemia Download PDFInfo
- Publication number
- CN104721276A CN104721276A CN201310749795.1A CN201310749795A CN104721276A CN 104721276 A CN104721276 A CN 104721276A CN 201310749795 A CN201310749795 A CN 201310749795A CN 104721276 A CN104721276 A CN 104721276A
- Authority
- CN
- China
- Prior art keywords
- parts
- alcohol
- vinegar
- leaching
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 62
- 239000000052 vinegar Substances 0.000 title claims abstract description 32
- 235000021419 vinegar Nutrition 0.000 title claims abstract description 32
- 208000031226 Hyperlipidaemia Diseases 0.000 title abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 74
- 239000007788 liquid Substances 0.000 claims abstract description 29
- 238000002386 leaching Methods 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 241000208340 Araliaceae Species 0.000 claims abstract description 19
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 18
- 235000008434 ginseng Nutrition 0.000 claims abstract description 18
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 239000006228 supernatant Substances 0.000 claims abstract description 8
- 238000003756 stirring Methods 0.000 claims abstract description 6
- 230000001954 sterilising effect Effects 0.000 claims abstract description 4
- 238000010992 reflux Methods 0.000 claims abstract description 3
- 210000004369 blood Anatomy 0.000 claims description 28
- 239000008280 blood Substances 0.000 claims description 28
- 201000005577 familial hyperlipidemia Diseases 0.000 claims description 22
- 239000000284 extract Substances 0.000 claims description 6
- 238000007654 immersion Methods 0.000 claims description 4
- 235000019640 taste Nutrition 0.000 claims description 3
- 239000006286 aqueous extract Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 235000008216 herbs Nutrition 0.000 claims description 2
- 239000002699 waste material Substances 0.000 claims description 2
- 230000003203 everyday effect Effects 0.000 claims 1
- 238000001914 filtration Methods 0.000 abstract description 9
- 239000000463 material Substances 0.000 abstract description 7
- 241001289529 Fallopia multiflora Species 0.000 abstract description 4
- 235000012907 honey Nutrition 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract description 2
- 244000272459 Silybum marianum Species 0.000 abstract 2
- 235000010841 Silybum marianum Nutrition 0.000 abstract 2
- 238000009835 boiling Methods 0.000 abstract 2
- 238000004140 cleaning Methods 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 21
- 230000006870 function Effects 0.000 description 21
- 235000019197 fats Nutrition 0.000 description 18
- 230000036541 health Effects 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 17
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
- 229940079593 drug Drugs 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 201000001320 Atherosclerosis Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 238000002560 therapeutic procedure Methods 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 230000029087 digestion Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 230000009471 action Effects 0.000 description 8
- 210000000988 bone and bone Anatomy 0.000 description 8
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 108010007622 LDL Lipoproteins Proteins 0.000 description 7
- 102000007330 LDL Lipoproteins Human genes 0.000 description 7
- 102000004895 Lipoproteins Human genes 0.000 description 7
- 108090001030 Lipoproteins Proteins 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 229930182470 glycoside Natural products 0.000 description 7
- -1 nitrogen-containing compound Chemical class 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- 230000002411 adverse Effects 0.000 description 6
- 235000013361 beverage Nutrition 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 230000005180 public health Effects 0.000 description 6
- CYGIJEJDYJOUAN-UHFFFAOYSA-N Isosilychristin Natural products C1=C(O)C(OC)=CC(C2C3C=C(C4C(C3=O)(O)OCC42)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 CYGIJEJDYJOUAN-UHFFFAOYSA-N 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 235000013402 health food Nutrition 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 208000006454 hepatitis Diseases 0.000 description 4
- 208000020346 hyperlipoproteinemia Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- HHXYJYBYNZMZKX-PYQRSULMSA-N 22(29)-Hopene Chemical compound C([C@]1(C)[C@H]2CC[C@H]34)CCC(C)(C)[C@@H]1CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@@H]1C(=C)C HHXYJYBYNZMZKX-PYQRSULMSA-N 0.000 description 3
- HHXYJYBYNZMZKX-UHFFFAOYSA-N 3,4:15,16-diepoxy-7-oxo-13(16),14-clerodadien-20,12-olide-(3alpha,4alpha)-form Natural products C12CCC3C4(C)CCCC(C)(C)C4CCC3(C)C1(C)CCC1C2(C)CCC1C(=C)C HHXYJYBYNZMZKX-UHFFFAOYSA-N 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 239000010282 Emodin Substances 0.000 description 3
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 3
- HEMJJKBWTPKOJG-UHFFFAOYSA-N Gemfibrozil Chemical compound CC1=CC=C(C)C(OCCCC(C)(C)C(O)=O)=C1 HEMJJKBWTPKOJG-UHFFFAOYSA-N 0.000 description 3
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
- 108010062497 VLDL Lipoproteins Proteins 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000002605 anti-dotal effect Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 3
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 235000021286 stilbenes Nutrition 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- UGJAEDFOKNAMQD-DVQDXYAYSA-N (-)-Falcarinol Natural products CCCCCCC\C=C\CC#CC#C[C@@H](O)C=C UGJAEDFOKNAMQD-DVQDXYAYSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- UGJAEDFOKNAMQD-MQNTZWLQSA-N (3S,9Z)-1,9-Heptadecadiene-4,6-diyn-3-ol Chemical compound CCCCCCC\C=C/CC#CC#C[C@@H](O)C=C UGJAEDFOKNAMQD-MQNTZWLQSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- NFZYDZXHKFHPGA-UHFFFAOYSA-N 17alpha-hydroxygofruside Natural products C12CC(C)(C)CCC2(C(=O)OC2C(C(O)C(O)C(CO)O2)O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OC(C(O)=O)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O NFZYDZXHKFHPGA-UHFFFAOYSA-N 0.000 description 2
- FZIPCQLKPTZZIM-UHFFFAOYSA-N 2-oxidanylpropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FZIPCQLKPTZZIM-UHFFFAOYSA-N 0.000 description 2
- HRGUSFBJBOKSML-UHFFFAOYSA-N 3',5'-di-O-methyltricetin Chemical compound COC1=C(O)C(OC)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 HRGUSFBJBOKSML-UHFFFAOYSA-N 0.000 description 2
- QHYWQIVTVQAKQF-UHFFFAOYSA-N 3,5-dihydroxy-2-phenylchromen-4-one Chemical compound OC=1C(=O)C=2C(O)=CC=CC=2OC=1C1=CC=CC=C1 QHYWQIVTVQAKQF-UHFFFAOYSA-N 0.000 description 2
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000256844 Apis mellifera Species 0.000 description 2
- 108010071619 Apolipoproteins Proteins 0.000 description 2
- 102000007592 Apolipoproteins Human genes 0.000 description 2
- QXQFFGOMXYKNBA-UHFFFAOYSA-N Chikusetsusaponin V Natural products CC1(C)CCC2(CCC3C(=CCC4C3(C)CCC5C(C)(C)C(CCC45C)OC6OC(C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C(=O)O)C2C1)C(=O)OC8OC(CO)C(O)C(O)C8O QXQFFGOMXYKNBA-UHFFFAOYSA-N 0.000 description 2
- NFZYDZXHKFHPGA-QQHDHSITSA-N Chikusetsusaponin-V Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CCC(C[C@H]14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NFZYDZXHKFHPGA-QQHDHSITSA-N 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 108010004103 Chylomicrons Proteins 0.000 description 2
- 241000431990 Drynaria sinica Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- UGJAEDFOKNAMQD-UHFFFAOYSA-N Falcarinol Natural products CCCCCCCC=CCC#CC#CC(O)C=C UGJAEDFOKNAMQD-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 208000035150 Hypercholesterolemia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 235000002791 Panax Nutrition 0.000 description 2
- 241000208343 Panax Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- IDDMFNIRSJVBHE-UHFFFAOYSA-N Piscigenin Natural products COC1=C(O)C(OC)=CC(C=2C(C3=C(O)C=C(O)C=C3OC=2)=O)=C1 IDDMFNIRSJVBHE-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 2
- RIAZZJBPJQWPIS-UHFFFAOYSA-N Silychristin Natural products COc1cc(ccc1O)C2OC3C(C=C(C=C3O)C4Oc5cc(O)cc(O)c5C(=O)C4O)C2CO RIAZZJBPJQWPIS-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000002155 anti-virotic effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 229940076810 beta sitosterol Drugs 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000003177 cardiotonic effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 230000002279 cholagogic effect Effects 0.000 description 2
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 2
- ZZBWSNKBZKPGAK-UHFFFAOYSA-N chrysophanol-9-anthrone Chemical compound C1=CC=C2CC3=CC(C)=CC(O)=C3C(=O)C2=C1O ZZBWSNKBZKPGAK-UHFFFAOYSA-N 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 2
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 229930003949 flavanone Natural products 0.000 description 2
- 235000011981 flavanones Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 229960003627 gemfibrozil Drugs 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000000745 gonadal hormone Substances 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000002443 hepatoprotective effect Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 201000002364 leukopenia Diseases 0.000 description 2
- 231100001022 leukopenia Toxicity 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- KKAHGGJBKUXDNQ-KRWDZBQOSA-N panaxynol Natural products CCCCCCCC=CC=CCC#C[C@@H](O)C=C KKAHGGJBKUXDNQ-KRWDZBQOSA-N 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 2
- BMLIIPOXVWESJG-LMBCONBSSA-N silychristin Chemical compound C1=C(O)C(OC)=CC([C@H]2[C@@H](C3=C(C(=CC(=C3)[C@@H]3[C@H](C(=O)C4=C(O)C=C(O)C=C4O3)O)O)O2)CO)=C1 BMLIIPOXVWESJG-LMBCONBSSA-N 0.000 description 2
- BMLIIPOXVWESJG-UHFFFAOYSA-N silychristin A Natural products C1=C(O)C(OC)=CC(C2C(C3=C(C(=CC(=C3)C3C(C(=O)C4=C(O)C=C(O)C=C4O3)O)O)O2)CO)=C1 BMLIIPOXVWESJG-UHFFFAOYSA-N 0.000 description 2
- CYGIJEJDYJOUAN-JSGXPVSSSA-N silydianin Chemical compound C1=C(O)C(OC)=CC([C@H]2[C@H]3C=C([C@@H]4[C@@](C3=O)(O)OC[C@@H]42)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 CYGIJEJDYJOUAN-JSGXPVSSSA-N 0.000 description 2
- 229960004245 silymarin Drugs 0.000 description 2
- 235000017700 silymarin Nutrition 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 2
- 229940032091 stigmasterol Drugs 0.000 description 2
- 235000016831 stigmasterol Nutrition 0.000 description 2
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- BMCJATLPEJCACU-UHFFFAOYSA-N tricin Natural products COc1cc(OC)c(O)c(c1)C2=CC(=O)c3c(O)cc(O)cc3O2 BMCJATLPEJCACU-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- QYCJAWYDGRZSTO-IRLTUAEKSA-N (2r,3r)-3,5,7-trihydroxy-2-[(2r,3s)-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1-benzofuran-4-yl]-2,3-dihydrochromen-4-one Chemical compound C1=C(O)C(OC)=CC([C@H]2[C@@H](C3=C(C(=CC=C3[C@@H]3[C@H](C(=O)C4=C(O)C=C(O)C=C4O3)O)O)O2)CO)=C1 QYCJAWYDGRZSTO-IRLTUAEKSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- YZAZXIUFBCPZGB-QZOPMXJLSA-N (z)-octadec-9-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O YZAZXIUFBCPZGB-QZOPMXJLSA-N 0.000 description 1
- GFAZHVHNLUBROE-UHFFFAOYSA-N 1-hydroxybutan-2-one Chemical compound CCC(=O)CO GFAZHVHNLUBROE-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- PNJBOAVCVAVRGR-PUAVFHROSA-N 2-[(5aR,5bR,7aS,11aS,11bR,13aR,13bS)-5a,5b,8,8,11a,13b-hexamethyl-1,2,3,3a,4,5,6,7,7a,9,10,11,11b,12,13,13a-hexadecahydrocyclopenta[a]chrysen-3-yl]propan-2-ol Chemical compound [C@H]12CC[C@@H]3[C@@]4(C)CCCC(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CCC1C(CC[C@]21C)C(C)(C)O PNJBOAVCVAVRGR-PUAVFHROSA-N 0.000 description 1
- OZDAOHVKBFBBMZ-UHFFFAOYSA-N 2-aminopentanedioic acid;hydrate Chemical compound O.OC(=O)C(N)CCC(O)=O OZDAOHVKBFBBMZ-UHFFFAOYSA-N 0.000 description 1
- ILPUOPPYSQEBNJ-UHFFFAOYSA-N 2-methyl-2-phenoxypropanoic acid Chemical compound OC(=O)C(C)(C)OC1=CC=CC=C1 ILPUOPPYSQEBNJ-UHFFFAOYSA-N 0.000 description 1
- PNJBOAVCVAVRGR-UDCAXGDQSA-N 22-Hopanol Chemical compound C([C@]1(C)[C@H]2CC[C@H]34)CCC(C)(C)[C@@H]1CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@@H]1C(C)(O)C PNJBOAVCVAVRGR-UDCAXGDQSA-N 0.000 description 1
- RXFAGYKLLRXFDX-UHFFFAOYSA-N 3-propylhexan-2-one Chemical compound CCCC(C(C)=O)CCC RXFAGYKLLRXFDX-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000256837 Apidae Species 0.000 description 1
- 241000256836 Apis Species 0.000 description 1
- 241000256846 Apis cerana Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N Aspartic acid Chemical compound OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 241001236122 Coprinopsis atramentaria Species 0.000 description 1
- 241000565633 Coprinus sterquilinus Species 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000092728 Eleutherococcus gracilistylus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000371997 Eriocheir sinensis Species 0.000 description 1
- ZHDRLFGZQZCZKX-BQOUFORSSA-N Fernene Chemical compound CC1(C)CCC[C@]2(C)C3=CC[C@@]4(C)[C@@H]5CC[C@H](C(C)C)[C@@]5(C)CC[C@]4(C)[C@H]3CC[C@H]21 ZHDRLFGZQZCZKX-BQOUFORSSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- DLTTWXWDLCGBRD-UHFFFAOYSA-N Hydroxyhopane Natural products CC12CCCC(C)(C)C1CCC1(C)C2CCC2C3(C)CCC(C(C)C)C3(O)CCC21C DLTTWXWDLCGBRD-UHFFFAOYSA-N 0.000 description 1
- 206010020675 Hypermetropia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 241000431987 Neocheiropteris fortunei Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010058116 Nephrogenic anaemia Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241000196124 Polypodiaceae Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 240000005893 Pteridium aquilinum Species 0.000 description 1
- 235000009936 Pteridium aquilinum Nutrition 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241001480055 Quercus mongolica Species 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- MZBGBHVFCYCYLX-UHFFFAOYSA-N Silydianin Natural products COc1cc(ccc1O)C2C3COC4(O)C3C=C(C5Oc6cc(O)cc(O)c6C(=O)C5O)C2C4=O MZBGBHVFCYCYLX-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241001563853 Sphallerocarpus gracilis Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 229960000516 bezafibrate Drugs 0.000 description 1
- IIBYAHWJQTYFKB-UHFFFAOYSA-N bezafibrate Chemical compound C1=CC(OC(C)(C)C(O)=O)=CC=C1CCNC(=O)C1=CC=C(Cl)C=C1 IIBYAHWJQTYFKB-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229960001214 clofibrate Drugs 0.000 description 1
- KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000010235 enterohepatic circulation Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229960002297 fenofibrate Drugs 0.000 description 1
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- RBRANZURTULKJD-UHFFFAOYSA-N ginsenoside Ro Natural products CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OC(C)(C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C(=O)O)C(C)(C)C5CCC34C)C2C1)C(=O)OC8OC(CO)C(O)C(O)C8O RBRANZURTULKJD-UHFFFAOYSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- ZOLPMMWNCLHKPX-UHFFFAOYSA-N ligustrin Natural products CC1=CCC2C1C3OC(=C)C(=O)C3C(O)CC2=C ZOLPMMWNCLHKPX-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007056 liver toxicity Effects 0.000 description 1
- 229940063720 lopid Drugs 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 239000002423 protozoacide Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000000246 remedial effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 229950004304 silidianin Drugs 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- QJVXKWHHAMZTBY-KSXIZUIISA-N syringin Natural products COc1cc(C=CCO)cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O QJVXKWHHAMZTBY-KSXIZUIISA-N 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses traditional Chinese medicine vinegar for treating hyperlipidemia. The traditional Chinese medicine vinegar for treating hyperlipidemia is prepared through the steps of taking 5 parts of ginseng, 10 parts of polygonum multiflorum, 5 parts of rhizoma drynariae, 5 parts of cortex acanthopanacis, 5 parts of silybum marianum, 10 parts of honey and 60 parts of table vinegar; selecting, cleaning and draining the five medicinal materials including the ginseng, the polygonum multiflorum, the rhizoma drynariae, the cortex acanthopanacis and the silybum marianum, placing the five medicinal materials into an alcohol leaching tank, adding 70% ethanol to soak in a way that the liquid level is higher than the surfaces of the medicinal materials, stirring for 15 minutes every two days, filtering an alcohol leaching solution after soaking for 7 days, transferring decoction dregs into a multifunctional extracting tank, adding 10 times of 70% ethanol to carry out reflux extraction for 120 minutes, filtering an ethanol solution, mixing the ethanol solution and the alcohol leaching solution, uniformly standing for a night, filtering supernatant liquid, recovering ethanol, and concentrating liquid medicine without alcohol smell for later use; adding 10 times of water into the decoction dregs in the multifunctional extracting tank, boiling at normal pressure for 120 minutes, and filtering the liquid medicine; then, adding 8 times of water to boil for 90 minutes, filtering the liquid medicine, removing dregs, mixing an alcohol extracting solution and water extracting solutions obtained in twice, uniformly mixing, standing for a night, filtering supernatant liquid, and concentrating to form clear paste; and adding the table vinegar to heat, adding the honey to mix uniformly, boiling for 30 minutes, cooling to be lower than 50 DEG C, finely filtering, carrying out split charging and sterilizing.
Description
1 art
The present invention relates to a kind of Chinese medicine acetum for the treatment of hyperlipemia, be especially suitable for the course of disease and drink in right amount without the hyperlipidemia patient longer-term of other severe disease slowly, there is therapeutical effect.This formula is suitable for preparing acetum, is also suitable for preparing the Chinese medicine preparation such as tablet, capsule, granule, pill simultaneously.Belong to field of traditional Chinese.
2 background technologies
2.1 modern medicines are to the discussion of hyperlipemia
Lipidemia (Lipaemia): namely there is abnormal significant quantities of fat in blood, as cholesterol lipoprotein (Lipoprotein): be namely present in the histone matter in blood plasma and lymph, it combines with fat or other lipids (as cholesterol), plays an important role in the lipid running of blood and lymph.Lipid is not soluted in water, and serum free fatty acid is combined with serum albumin, triacylglycerol, free cholesterol, cholesterol ester and phospholipid then from different apolipoprotein (apolipoprotein; Apo) (hydrophilic) lipoprotein is combined into.Lipoprotein is divided into four kinds: high density lipoprotein (HDL), low density lipoprotein, LDL (LDL), very low density lipoprotein (VLDL) (VLDL) and Chylomicron (CM).Containing certain density above-mentioned various albumen in Healthy Human Serum, under some physiology and pathologic condition, its content, composition and character can change, and abnormal lipoprotein can be had during some disease to occur.As lipid or lipoprotein content too high, or lipoprotein molecule 26S Proteasome Structure and Function change, containing occurring that atherogenicity (AS) acts on, finally cause multiple cardiovascular, blood pressure, blood lipid disorders.
Hyperlipoproteinemia is divided into constitutional (or heritability) and the large class of Secondary cases two, primary hyperlipoproteinemia reason it be unclear that, and secondary hyperlipoproteinaemia is then closely related with Kou cardiopathia (CHD), atherosclerosis (AS).Namely US and European to be grown up hyperlipemia diagnosis and treatment project respectively within 1988, delivering ATP II (NCEP) and EAS.China formulated in 1997 and announces first " dyslipidemia " remedial proposal.
The control of hyperlipoproteinemia: (1) reduces too high serum TC and LDL.C level, to prevent the formation of AS, especially must strictly control suffering from CHD person.(2) adjustment of diet, to various types of hyperlipoproteinemia, first answers adjustment of diet, keeps on a diet, take exercises.(3) Drug therapy: Carboxymethylcellulose salt derivative (fibric acid) or clofibrate derivant; Fenofibrate (Feaofibrate), gemfibrozil (Gemfibrozil.Lopid), tea Zha Beite (Bezafibrate) etc.But these Drug therapys and resultant effect wait to evaluate.
Clearly statement all without " hyperlipemia " in Chinese medical book, modern Chinese medicine research worker relies on modern science and technology progress, the chemical composition of foundation Chinese crude drug is in conjunction with modern pharmacology pharmacodynamics and clinical verification experience, the Chinese medicine that screening has " blood fat reducing " to act on carries out reducing too high serum TC and LDL level to hyperlipemia, to prevent the formation of AS, and reach the object of control.
2.2 list of references
(1) Chen Haozhu chief editor " practical internal medicine ", ISBN7-117-04313X, People's Health Publisher publishes, April in 2002 the 11st edition.
(2) Zhou Wenguan etc. compile " newly organized tcm clinical practice handbook " ISBN7-80022-555-0 Golden Shield publishing house JIUYUE in 1993 the 1st edition.
(3) Lu Zhaolin etc. put school Shennong's Herbal towering Wu Jin etc. and state, clearly. and Sun Xing spreads out volume ISBN7-5381-2560-4 Liaoning medical courses in general technology publishing house August in 1997 the 1st edition.
(4) Niu Zhanbing writes classical Chinese medicine and orders to arrest Huangdi's Internal Classics ISBN7-5375-1518-8/R-297 Hebei Science Press March in 1994 the 1st edition.
(5) clear-Wu Qian etc. compile Golden Mirror of Medicine ISBN7-117-00728-1/R.729 People's Health Publisher April nineteen ninety-five the 2nd edition
(6) She Jing etc. compile " Chinese medicine modern study and application " ISBN7-5077-1318-0 Xueyuan Press January in 1998 the 1st edition.
(7) Xie Zongwan edits " national Chinese herbal medicine compilation " ISBN7-117-02380-5/8.285, People's Health Publisher October in 1996 the 2nd edition.
(8) Ding Zhaomeng chief editor's " herbal medicine efficacy and clinical " ISBN7-5067-1925-8/R.285, China Medical Science Press February in 1999 the 1st edition.
(9) Liu Guojie edits " pharmaceutics " standard book number: 14048-4693, People's Health Publisher.February in 1985 the 2nd edition;
(10) Fan Biting edits " pharmacy of Chinese materia medica " ISBN7-5323-4439-8/R-1178, January in 1997 the 1st edition.
3 summary of the invention
The present invention relates to a kind of Chinese medicine acetum for the treatment of hyperlipemia, the Chinese medicine with blood fat reducing function has screened in system, be dosage form in conjunction with screening and optimizing Traditional Chinese herbal vinegar, for hyperlipemic patients provides it to need longer-term medication blood fat reducing symptom management to be in progress and avoid causing other complicated Chinese medicine acetum as diseases such as diabetes (being called for short " the clear vinegar drink of blood fat "), utilize Chinese medicine be suitable for take good care of health clothing is used and side effect is lighter advantage and the Chinese medicine acetum as " beverage " dosage form taking convenience for a long time.
3.1 reagent combination
Radix Ginseng 5 parts, Radix Polygoni Multiflori 10 parts, Rhizoma Drynariae 5 parts, Cortex Acanthopancis 5 parts, Herba Silybi mariani 5 parts, Mel 10 parts, vinegar 60 parts.Note: the every kind specifically amount of taking should in the 95%-105% of scalar, and if Radix Polygoni Multiflori 10 parts of batch are 100kg, then the actual amount of taking should between 95kg-105kg.
3.2 technical process
Get Radix Ginseng, Radix Polygoni Multiflori, Rhizoma Drynariae, Cortex Acanthopancis, Herba Silybi mariani gomi herbs pick up pick, clean, drench does, put in alcohol leaching tank and add 70% soak with ethanol, make liquid cross object plane, within every 2 days, stir 15min, flood leaching alcohol immersion after 7 days, medicinal residues dislocation multi-function extractor, adds 10 times amount 70% alcohol reflux 120min, leaching alcohol liquid, merge with alcohol immersion, mixing hold over night, leaching supernatant reclaims ethanol, and remaining several medicinal liquid without alcohol taste is for subsequent use; Medicinal residues in multi-function extractor add 10 times of water gaging normal pressures and boil 120min, leaching medicinal liquid; Add 8 times amount water boil 90min again, leaching medicinal liquid, waste, merge alcohol extract liquid and twice aqueous extract, mixing, hold over night, leaching supernatant, is condensed into clear paste; Add vinegar heating, add purified water 2 times amount, add Mel mixing, boil 30min, let cool to less than 50 DEG C, fine straining, subpackage, namely sterilizing obtains the Chinese medicine acetum " the clear vinegar drink of blood fat " for the treatment of hyperlipemia.
3.3 functions cure mainly and usage and dosage
(1) function cures mainly: invigorating QI to consolidate the body surface resistance, grows spleen nourishing the liver, diuresis toxin expelling.For the lipid-lowering therapy of hyperlipemia.
(2) usage and dosage: oral, each serving 100ml, day takes 2-3 time, takes more than 30 days continuously.
3.4 drug efficacy assays
(1) Radix Ginseng: this product is the dry root of Araliaceae Radix Ginseng Panax ginseng C.A.Mey.
Nature and flavor: sweet, micro-hardship are flat.
Function with cure mainly: strongly invigorating primordial QI, multiple arteries and veins takes off admittedly, and invigorating the spleen to benefit the lung, promotes the production of body fluid, and calms the nerves.For weak body and prostration, cold extremities faint pulse, insufficiency of the spleen lack of appetite, the deficiency of the lung is breathed with cough, and Tianjin wound is thirsty, and interior-heat disappears and drinks, prolonged illness weakness with emaciation, and palpitation with fear insomnia, sexual impotence is sombre, heart failure, cardiogenic shock.
Main containing chemical composition: soaping agents: more than the 30 kind of ginsenosides such as Chikusetsusaponin V (ginsenoside Ro), volatile ingredient: Panaxynol (Panaxynol), β-panacene (β-panascnsene), octanal (octanal), capryl alcohol (Octanol), sad (Octanoic acid) etc., organic acid and ester: citric acid (Citric acid), Rhizoma Corydalis (Fumaric acid), oleic acid (Oleic acid), panax acid (panax acid), triglyceride (Tciglycanride) etc., sterol and glycoside thereof: cupreol (β-sitosterol), stigmasterol (Stigmasterol), daucosterol (daucostcrol) etc., polypeptide, protein and enzyme, nitrogen-containing compound, vitamin, lignin, flavonoid, monosaccharide and polysaccharide, maltol, Cu, Zn, more than the ten kind of inorganic elements such as Fe.
Pharmacological action: (1) can be strengthened corticocerebral process of excitation and process of inhibition to central nervous system and be balanced, makes anxiety cause disorderly nervous process to be recovered, hypermnesis, antifatigue effect.(2) Endocrine system can increase the defence capability of body to destructive stimulus, strengthen organism adaptation, activate hypophysis and interrenal system effect, promote gonadal hormone secretion, male spermatozoa in testis number is increased, make female uterus and ovary accelerated development and ovulation, promote that rutting period extends, illustrate that Radix Ginseng all has gonadal hormone and the effect of promoting sexual gland hormone sample to male, female.(3) to immunologic function energy enhancing human body immunity function, prevent and treat leukopenia, improve the content of Healthy Individuals conversion ratio and gamma globulin, thus improve body's immunity.(4) can heart body be regulated to cardiovascular, blood vessel dilating, reduce high blood low, regulate hypotension shock, effect that prevention of arterial is atherosis.(5) can hyperglycemia be reduced to substance metabolism, reduce lipoprotein (blood fat reducing) in blood, promote protein and RNA synthesis, promote the division of medullary cell, make red, leukocyte rising, growth promoting effects.(6) antitumor action, anti-aging effects, antiinflammatory action, antivirus action, radiation resistance etc.
China's Chinese medicine classics Shennong's Herbal: " Radix Ginseng, sweet in the mouth are slightly cold.Vertical tonifying five ZANG-organs, peace spirit, determine soul, spasmolytic is throbbed with fear, except pathogen, improving eyesight, happily, Fructus Alpiniae Oxyphyllae.Clothes of a specified duration are made light of one's life by commiting suicide, and prolong life.One famous person's rank, a Coprinus atramentarius (Bull.) Fr. (Coprinus sterquilinus Fr.).Go out mountain valley.Wei Wu general day: Radix Ginseng, a Rhizoma Panacis Japonici, a SHENCAO, a Sphallerocarpus gracilis, a Herba Wedeliae Wallichii, a famous person is micro-, a beautiful essence." it serves to show that ancients are farsighted already to Radix Ginseng function.
Clinical practice: opinion rescues shock, treatment arrhythmia, treatment coronary heart disease, treatment hypercholesterolemia, treatment anticoagulant, regulates blood pressure, treatment pulmonary heart disease, treatment leukopenia, treatment acute hepatopathy, treatment dyspepsia, treatment renal anemia, treatment tumor, treatment diabetes, therapeutic malfunction etc., more at most for health care.
Note: (1) Chinese Pharmacopoeia version in 2010 first 8 pages.(2) She Jing etc. compile the 1st edition 19-172 page in " Chinese medicine modern study and application " ISBN7-5077-1318-0 Xueyuan Press January in 1998.(3) Xie Zongwan edits " national Chinese herbal medicine compilation " ISBN7-117-02380-5/8.285, People's Health Publisher October in 1996 the 2nd edition.(4) the new medical college in Jiangsu compiles " Chinese medicine voluminous dictionary " ISBN7-5323-0842-1/R-230, Science and Technology of Shanghai publishing house May in 1986 the 1st edition, the 15th printing May in 2003,29-38 page.(5) Ding Zhaomeng chief editor's " herbal medicine efficacy and clinical " ISBN7-5067-1925-8/R.285, China Medical Science Press February in 1999 the 1st edition.(6) clear Sun Xing spreads out a volume Shennong's Herbal ISBN-7-5381-2560-4, Liaoning Science Press, August in 1997 the 1st edition.
(2) Radix Polygoni Multiflori: this product is the dry root of polygonum multiflorum thunb Polygonum multiflorum Thunb., ministry of Health of China is classified as " can be used for the article of health food ".
Nature and flavor with return footpath: bitter, sweet, puckery, temperature; Return liver, the heart, kidney footpath.
Function with cure mainly: detoxify, eliminating carbuncle, loosening bowel to relieve constipation.For the sick carbuncle sore of scrofula, rubella pruritus, dryness of the intestine constipation; Hyperlipemia is demonstrate,proved.
Chemical composition: the various trace elements such as emodin (emodin), chrysophanol (chrysophanol), chrysophanic acid (rhein), chrysophanic acid anthrone (chrysophanol anthrone), tricin (tricin), Quercetin, Fructus Aristolochiae amide, glucose glycoside, stilbene glycoside, cupreol, carotene, gallic acid, Zn, Cu, Si, ovum phosphoric acid, crude fat, nitrogen, starch, tannin, mineral etc., existing clear and definite composition stilbene glycoside is main blood fat reducing composition.
Pharmacological action: energy decreased heart rate, increases coronary flow, cardiotonic; Reduce plasma cholesterol, triglyceride and beta Lipoprotein, improve lipid metabolism, prevents blood fat from increasing and arteriosclerosis; Delaying senility function, delays involution of thymus and atrophy, enhancing immunity.Facilitation is had, the kidney invigorating to epinephrine and adrenocortical hormone; Functions of loosening bowel relieving constipation; There is growth promoting function to grain system CFU-GM, enrich blood; Antitumor action; Improving growth effect, etc.
Clinical practice: treatment hyperlipemia, treatment neurasthenia, treatment psychotic disorder etc.Be the first-selected Chinese medicine for the treatment of hyperlipemia at present.
Note: She Jing etc. compile " Chinese medicine modern study and application " ISBN7-5077-1318-0 Xueyuan Press January in 1998 the 1st edition 2310 pages.
(3) Rhizoma Drynariae: this product is the dry rhizome of Plants of Polypodiaceae Mongolian oak Herba pteridii latiusculi Drynariafortunei (Kze.) J.Sm. or drynaria baronii Diels D.baronii (Christ) Diels.Ministry of Health of China is classified as " can be used for the article of health food ".
Nature and flavor with return footpath: bitter, warm; Return kidney, liver footpath.
Function with cure mainly: the kidney invigorating bone strengthening, continuous hinder pain relieving.For lumbago due to renal deficiency, ear toot deafness, odontoseisis, falls in flutterring and frustrates, injured bone; External treatment class is bald, vitiligo.
Chemical composition: 22(29)-Hopene (diploptene), A Pa-21-alkene (hop-21-cne), (+)-Hopan-22-ol (diplopterol), fernene, bracken alkene; Naringin, flavanone glycoside, D-Glucose, L-rhamnose, starch etc.
Pharmacological action: promote that bone is to the absorption of calcium, control hormone causes osteoporosis, cardiotonic, blood fat reducing and liver protection effect etc.
The active component flavanone glycoside of Rhizoma Drynariae can reduce serum levels of triglyceride and cholesterol; Rhizoma Drynariae polysaccharide hydrochlorate can protect liver and adrenal organelle; the damage of hypercholesterolemia in anti-cell; thus enhancing cell function; anti-hyperlipidemia blood vessel damage short of money; catch into liver, adrenal gland's inner cholesterol metabolic process, thus make to decline without cholesterol in atherosis district aorta wall, liver, adrenal gland, guarantee hyperlipidemia blood fat reducing.
Clinical practice: treatment hyperlipemia, treatment ankylosing spondylitis etc.
Note: She Jing etc. compile " Chinese medicine modern study and application " ISBN7-5077-1318-0 Xueyuan Press January in 1998 the 1st edition 3333 pages.
(4) Cortex Acanthopancis: this product is the dry root bark of Araliaceae acanthopanax gracilistylus Acanthopanax gracilistylus W.W.Smith.Ministry of Health of China is classified as " can be used for the article of health food ".
Nature and flavor: acrid, bitter, warm.
Effect: wind-damp dispelling, invigorating the liver and kidney, bone and muscle strengthening.
Cortex Acanthopancis is mainly containing Radix Et Caulis Acanthopanacis Senticosi glucoside (eleurthexoside B.), ligustrin (syringin), cupreol (β-sitosterol), daucosterol (daucostcrol), tannin, vitamin (A, B), Palmic acid, linolenic acid etc.There is antiinflammatory action, strengthen immunity function, hypotensive activity, hypoglycemic activity, etc.Note: She Jing etc. compile " Chinese medicine modern study and application " ISBN7-5077-1318-0 Xueyuan Press January in 1998 the 1st edition 997 pages.
(5) Herba Silybi mariani: this product is the dry herb of feverfew Herba Silybi mariani Silybam marianum (L.) Caentn..
Nature and flavor: bitter, cool.
Function with cure mainly: heat-clearing and toxic substances removing, protects the liver, function of gallbladder promoting, anti-X-ray.For acute, chronic hepatitis, hepatitis interstitialis chronica, metabolism toxic liver injury, sand Stranguria.
Chemical composition: silymarin (Silrbin), silidianin (Silydianin), Silychristin (Silychristin), silybonol (isosilychristin), dihydroxyflavone alcohol etc.
Pharmacological action: hepatoprotective effect, regulating blood lipid action, alleviates cerebral edema effect, radiation resistance, anti-erythrocyte haemolysis, suppresses diabetes development effect, control Atherosclerosis, enterohepatic circulation effect.Special hepatoprotective successful.
Clinical practice: treatment acute icterohepatitis type hepatitis, chronic hepatitis, treatment hyperlipemia, antituberculotics liver toxicity, treatment hepatitis B, treatment alcoholic hepatitis, treatment liver portal vein anastomosis etc.
Note: She Jing etc. compile " Chinese medicine modern study and application " ISBN7-5077-1318-0 Xueyuan Press January in 1998 the 1st edition 5559 pages.
(6) Mel: this product is Apidae insecticide apis cerana Apis ceyana fabricius, or the honey that apis mellifera Linnaeus Apis mellifera Linnaeus. makes.Ministry of Health of China is classified as " being food and the article of medicine ", food hygienic standard: GB14963-2003.Nature and flavor with return footpath: sweet, flat; Return lung, spleen, large intestine footpath.Function with cure mainly: invigorating middle warmer is moisturized, pain relieving, removing toxic substances.For the empty pain of gastral cavity abdomen, dryness of the lung dry cough, dryness of the intestine constipation; External treatment skin infection is not held back, burn due to hot liquid or fire.Chemical composition: saccharide: glucose (Glucose) 35%, fructose (fructose) 36%, sucrose (Sucrose) 2.6%, maltose (maltose), dextrin etc.; Organic acid: citric acid (citric acid), malic acid (malic acid), succinic acid, formic acid, acetic acid etc.; Enzyme: amylase (dcastase), invertase (transferase), oxidoreductase, peroxidase etc.; Vitamins: vitamin A, B, B2, B6, C, D, K, nicotinic acid, pantothenic acid, biotin, folic acid, acetylcholine etc.; Amino acids: aspartic acid (ASP), glutamic acid (GLU), leucine (LEU), threonine (THR), serine (SER), glycine (GLY), alanine (ALA), valine (VAL), isoleucine (ILE), lysine (LYS) etc.; Still containing protein, natural gum, pigment, waxiness, natural perfume material, the elements such as K, Fe, Ca, Na, Cu, Mn, P.
Pharmacological action: antibacterial action, antifungic action, antivirus action, protozoacide effect, antitumor action, effect for reducing blood fat, negativity cardiac muscle blood vessel dilating hypotensive effect, promotes gastric secretion effect etc.
Clinical practice: treatment hypertension, hyperlipidemia, treatment intestinal obstruction, treatment burn and scald, treatment ulcerate disease skin infection, treatment constipation, treatment Venenum apis and neuro intoxication, anemia, prostate hyperplasia, beauty treatment etc.Note: She Jing etc. edit " Chinese medicine modern study and application " ISBN7-5077-1318-0, and Xueyuan Press January in 1998 the 1st edition the 5120th page waits document.
(7) vinegar: standard GB/T 2719-2003.For the liquid containing acetic acid led to rice, wheat, highgrain or wine, ethanol etc.Another name: Bitters, pure jealous woman, rice vinegar.Main containing higher alcohols, hydroxy butanone, dipropyl acetone, butyl alcohol, acetaldehyde etc., acetic acid content 3-5%; Nature and flavor: bitter, temperature.Return liver, stomach warp.Function: dissipating blood stasis, hemostasis, removing toxic substances, parasite killing.Full nitrogen containing 0.005%-0.2% in vinegar, is equivalent to the protein of 1%, and in full nitrogen, aminoacid is containing 40%-50%, comprises the free amino acid of more than 18 kinds." book on Chinese herbal medicine is looked for the truth ": " rice vinegar, acid is main holds back, therefore book many sections of dissipating blood stasis removing toxic substances, the therapeutic method to keep the adverse QI flowing downwards helps digestion.To vinegar both acid (receipts), cloud can fall apart the swollen person of pain again, loose then to disappear, routed then to fall apart outward, and receipts place falls apart to locate event ear ".TAO Hong-Jing: " jealous woman wine is use, without not entering.Better.With meat and fish dishes bitterness, for exhaling Bitters ".Supplement to the Herbal: vinegar " removing blood stasis dirty , Chu wei block heavily fortified point is long-pending, helps digestion; kill vicious, broken stagnation of QI, in the heart sour water phlegm retention ", essentials of Matea Medica: " therapeutic method to keep the adverse QI flowing downwards helps digestion for dissipating blood stasis, removing toxic substances; appetizing gas ", and " occupying diet with breath general " " sky stomach, nourishing the liver; strong muscle, warm bone, relieving alcoholic intoxication; help digestion, the therapeutic method to keep the adverse QI flowing downwards exorcises evil spirits, and separates all poison of fish Eriocheir sinensis aquatic animals ".Note: the new medical college in Jiangsu compiles " Chinese medicine voluminous dictionary " ISBN7-5323-0843-X/R231, Science and Technology of Shanghai publishing house, 2600 pages (volume two).
In a word, Radix Ginseng strongly invigorating primordial QI, multiple arteries and veins takes off admittedly, invigorating the spleen to benefit the lung, and spermatogenesis is calmed the nerves; Radix Polygoni Multiflori removing toxicity for eliminating carbuncles, loosening bowel to relieve constipation; Rhizoma Drynariae the kidney invigorating bone strengthening, continues and hinders pain relieving; Cortex Acanthopancis wind-damp dispelling, invigorating the liver and kidney, bone and muscle strengthening; Herba Silybi mariani hepatic cholagogic; Dissipating blood stasis analgesic therapy, relieving cough and resolving phlegm; Mel invigorating middle warmer is moisturized, analgesic antidotal; Under vinegar, vapour helps digestion; Be combined with invigorating QI to consolidate the body surface resistance, grow spleen nourishing the liver, the strong muscle of the kidney invigorating, effect of dampness removing toxin expelling.The pharmaceutical research of 6 taste Chinese medicines all has effect for reducing blood fat, and clinical being all respectively used to treats hyperlipemia, and curative effect certainly.Particularly the active ingredient stilbene glycoside of Radix Polygoni Multiflori is confirmed to have cholesterol, triglyceride and beta Lipoprotein in definite reduction blood plasma by pharmaceutical research, and blood fat reducing function is definite.
3.5 guardian technique
(1) dosage form selection
For the clinical fact that hyperlipidemia patient is mutually close with AS and CHD disease, that is patient can take the medicine for AS and CHD simultaneously, is the mental burden making patient " take medicine too many, once a lot of ", and select the Chinese medicine acetum of beverage formula, long-term prescription, bioavailability is high, and there is no incompatibility (known at present) with other chemicalses, the toxic and side effects of Chinese medicine is low, as acetum beverage, conveniently drink at any time, therefore select acetum to be suitable for the most.
(2) prescription is concise
According to the dialectical treatmert principle of modern Chinese medicine to hyperlipemia, with the medicine strongly invigorating primordial QI of the large benefit of Radix Ginseng in side, vital base and primordial QI consolidating, the first-selected Chinese medicine of Radix Polygoni Multiflori blood fat reducing is monarch drug altogether; Rhizoma Drynariae, Cortex Acanthopancis invigorating the liver and kidney, bone and muscle strengthening are ministerial drug altogether; Herba Silybi mariani hepatic cholagogic is adjuvant drug; Mel invigorating middle warmer is moisturized, analgesic antidotal, and under vinegar, vapour helps digestion for making medicine; Mel is sweet, and flat, invigorating middle warmer is moisturized, analgesic antidotal, the medicine of the above-mentioned bitter cold of scalable, and square property of traditional Chinese is sweet, pungent, bitter, and cold, Wen Liangjun has coordination, harmony.Vinegar is the medicine of " therapeutic method to keep the adverse QI flowing downwards helps digestion ", and mostly fat for hyperlipidemia patient, digestive function is weak, take vinegar as guiding drug, has and to navigate the effect of adding fuel to the flames by means of water, and therefore prescription is undoubtedly best choice and selects.
(3) medical material extracts active ingredients purification techniques
In side of the present invention, as ginsenoside is soluble in ethanol, its cupreol is insoluble in water, in Radix Polygoni Multiflori, emodin is soluble in ethanol and is insoluble in water, silymarin is water-soluble is hardly soluble in ethanol, Rhizoma Drynariae is containing cupreol, 22(29)-Hopene is insoluble in water and is soluble in ethanol, Cortex Acanthopancis glucoside-containing, the materials such as cupreol Yu Shui hard to tolerate, are all soluble in organic solvent and are comparatively insoluble in water.So the extraction of the present invention to Effective Component of Chinese Medicine have employed room temperature alcohol leaching and circumfluence distillation, then produce active ingredient, the impurity such as peaceful filtering silt, phlegmatic temperament by the mode that water boil extracts for 2 times, concentrated refining, with vinegar dilution, add Mel seasoning, last damp and hot autoclaving.As can longer-term storage acetum beverage not with chemical preservative, guarantee safe for drinking.
3.6 beneficial effects of the present invention
(1) find when being health check-up substantially for hyperlipidemia patient, simultaneously can be closely adjoint mutually with complicated serious symptoms such as AS and CHD, need the feature of long-run adjustment diet, Long-term taking medicine, select acetum, in vinegar solution, add the Effective Component of Chinese Medicine that energy blood fat reducing improves symptom, beverage formula dosage form is made by Modern preparations Technology, patient takes as beverage, and bioavailability is high, overcomes again to take medicine the difficult problem of complicated procedures for a long time, taking convenience, effective.
(2) Chinese medicines such as Radix Ginseng, Radix Polygoni Multiflori, Rhizoma Drynariae, Cortex Acanthopancis, Herba Silybi mariani, Mel are selected all to meet the regulation of ministry of Health of China " notice about further specification healthy food material management " dayfile February 28 in 2002 and list among " being food and the article of medicine ", " can be used for the article of health food ", so the present invention is as a kind of Chinese medicinal health-care drink, legitimately to prevent and cure diseases again.
(3) vinegar itself is the health food flavoring agent of a kind of " therapeutic method to keep the adverse QI flowing downwards helps digestion ", again that “ Chu wei block heavily fortified point is long-pending " medicine; " hyperlipemia " how because of be addicted to drink and obesity with AS and CHD disease, with the thing of " therapeutic method to keep the adverse QI flowing downwards helps digestion " be carrier with fat-reducing effect medicine, disease is improved.
In prescription of the present invention, vinegar is standard GB/T 2719-2003 tablet vinegar, and all raw material is national standard, has food safety guarantee.
4 detailed description of the invention
4.1 prescription compositions: Radix Ginseng 5 parts, Radix Polygoni Multiflori 10 parts, Rhizoma Drynariae 5 parts, Cortex Acanthopancis 5 parts, Herba Silybi mariani 5 parts, Mel 10 parts, vinegar 60 parts.
4.2 functions cure mainly: invigorating QI to consolidate the body surface resistance, grow spleen nourishing the liver, diuresis toxin expelling.For the lipid-lowering therapy of hyperlipemia.
4.3 usage and dosages: oral, each serving 100ml, day takes 2-3 time, takes more than 30 days continuously.
4.4 raw material quality standards
(1) Radix Ginseng: Chinese Pharmacopoeia version in 2010 first 8 pages, Ministry of Public Health can be used for the article of health product.
(2) Radix Polygoni Multiflori: Chinese Pharmacopoeia version in 2010 first 164 pages, Ministry of Public Health can be used for the article of health product.
(3) Rhizoma Drynariae: Chinese Pharmacopoeia version in 2010 first 174 pages, Ministry of Public Health can be used for the article of health product.
(4) Cortex Acanthopancis: Chinese Pharmacopoeia version in 2010 first 61 pages, Ministry of Public Health can be used for the article of health product.
(5) Herba Silybi mariani: Chinese Pharmacopoeia version in 2010 first 76 pages, Ministry of Public Health can be used for the article of health product.
(6) Mel: Chinese Pharmacopoeia version in 2010 first 337 pages, Ministry of Public Health is food and the article of medicine.。
(7) vinegar: GB2719-2003 national standard.
4.5 technological procedure
(1) Radix Ginseng, Radix Polygoni Multiflori, Rhizoma Drynariae, Cortex Acanthopancis, Herba Silybi mariani are carried out picking up picking, abandon impurity, rinse with water, drench is done, section;
(2) put in alcohol leaching cylinder by above-mentioned decoction pieces, add 70% soak with ethanol, liquid crosses object plane, covers tightly, and soaks 1 week, within every two days, stirs 1 time, covers tightly;
(3) leaching alcohol leaching liquid, medicinal residues dislocation multi-function extractor, adds 10 times amount 70% ethanol, makes liquid cross object plane, and reduced-pressure backflow extracts 120min, and let cool, leaching ethanol medicinal liquid, merges with alcohol leaching liquid;
(4) by ethanol medicinal liquid hold over night, leaching supernatant, imports in efficient concentration device, concentrating under reduced pressure, collects ethanol (next time applies mechanically), be condensed into clear paste for subsequent use.
(5) multi-function extractor Chinese medicine slag is added 10 times of water gagings again, normal pressure boils carries 120min, leaching medicinal liquid; 2nd 8 times amount that add water, normal pressure boils carries 90min, leaching medicinal liquid, merges secondary filtrate, hold over night, medicinal residues reject;
(6) the above-mentioned medicinal liquid supernatant of leaching, import in efficient concentration device, concentrating under reduced pressure becomes clear paste, for subsequent use;
(7) by ethanol extraction clear paste, the mixing of water extract clear paste, add vinegar, Mel, stir, add 2 times amount purified water, heated and boiled 15min, do not stop to stir, let cool to room temperature, accurate filtration, subpackage;
(8) with moist heat sterilizer 0.1pma115 DEG C of 25min sterilizing, labeling, vanning, to obtain final product.
4.6 specifically implement example
Radix Ginseng 5kg, Radix Polygoni Multiflori 10kg, Rhizoma Drynariae 5kg, Cortex Acanthopancis 5kg, Herba Silybi mariani 5kg, Mel 10kg, vinegar 60kg, implement according under declaration material description of the present invention " 4.5 technological procedure " item, must treat the Chinese medicine acetum of hyperlipemia.
Function cures mainly: invigorating QI to consolidate the body surface resistance, grows spleen nourishing the liver, diuresis toxin expelling.For the lipid-lowering therapy of hyperlipemia.
Usage and dosage: oral, each serving 100ml, day takes 2-3 time, takes more than 30 days continuously.
Claims (1)
1. treat a Chinese medicine acetum for hyperlipemia, it is characterized in that: get Radix Ginseng 5 parts, Radix Polygoni Multiflori 10 parts, Rhizoma Drynariae 5 parts, Cortex Acanthopancis 5 parts, Herba Silybi mariani 5 parts, Mel 10 parts, vinegar 60 parts; Radix Ginseng, Radix Polygoni Multiflori, Rhizoma Drynariae, Cortex Acanthopancis, Herba Silybi mariani gomi herbs are picked up pick, clean, drench does, put in alcohol leaching tank and add 70% soak with ethanol, make liquid cross object plane, within every 2 days, stir 15min, flood leaching alcohol immersion after 7 days, medicinal residues dislocation multi-function extractor, adds 10 times amount 70% alcohol reflux 120min, leaching alcohol liquid, merge with alcohol immersion, mixing hold over night, leaching supernatant reclaims ethanol, and remaining several medicinal liquid without alcohol taste is for subsequent use; Medicinal residues in multi-function extractor add 10 times of water gaging normal pressures and boil 120min, leaching medicinal liquid; Add 8 times amount water boil 90min again, leaching medicinal liquid, waste, merge alcohol extract liquid and twice aqueous extract, mixing, hold over night, leaching supernatant, is condensed into clear paste; Add vinegar heating, add Mel mixing, boil 30min, let cool to less than 50 DEG C, fine straining, subpackage, sterilizing, the Chinese medicine acetum (the clear vinegar drink of blood fat) of hyperlipemia must be treated; Drink 100ml, every day 2-3 time, 30 days was 1 course for the treatment of at every turn.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310749795.1A CN104721276A (en) | 2013-12-24 | 2013-12-24 | Traditional Chinese medicine vinegar for treating hyperlipidemia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310749795.1A CN104721276A (en) | 2013-12-24 | 2013-12-24 | Traditional Chinese medicine vinegar for treating hyperlipidemia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104721276A true CN104721276A (en) | 2015-06-24 |
Family
ID=53446072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310749795.1A Pending CN104721276A (en) | 2013-12-24 | 2013-12-24 | Traditional Chinese medicine vinegar for treating hyperlipidemia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104721276A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1113778A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Preparation for treating senile diseases |
CN1139153A (en) * | 1995-06-23 | 1997-01-01 | 钟定良 | Ginseng-Polygonum multiflorum tonic liquid and its prepn |
-
2013
- 2013-12-24 CN CN201310749795.1A patent/CN104721276A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1113778A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Preparation for treating senile diseases |
CN1139153A (en) * | 1995-06-23 | 1997-01-01 | 钟定良 | Ginseng-Polygonum multiflorum tonic liquid and its prepn |
Non-Patent Citations (2)
Title |
---|
于新等: "《药食同源物品使用手册》", 31 July 2012, 中国轻工业出版社 * |
樊蔚虹: "《高血脂饮食养生宝典》", 31 May 2013, 陕西科学技术出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103719498B (en) | A kind of Siberian solomonseal rhizome health-care tea improving immunity and preparation method thereof | |
CN108524814A (en) | A kind of Chinese medicine composition and preparation method thereof for reducing blood glucose | |
CN104107349A (en) | Chinese herbal medicine for three-hypers patients, and its administration method | |
Shin et al. | Current status and clinical studies of oriental herbs in sexual medicine in Korea | |
CN108403841A (en) | A kind of Chinese medicine composition and preparation method thereof for treating myasthenia gravis | |
CN103301413A (en) | Traditional Chinese medicine composition for treating hyperlipemia and hyperglycemia | |
CN103301267B (en) | Traditional Chinese medicine composition for treating hypertension and/or atherosclerosis and application thereof | |
CN104189520B (en) | A kind of antilipemic Chinese herbal medicine preparation and preparation method | |
CN111643581B (en) | Traditional Chinese medicine composition with weight-losing effect, sachet containing traditional Chinese medicine composition and preparation method of sachet | |
CN105194421A (en) | Self-heal health-care oral solution capable of reducing blood fat and preparation method thereof | |
CN104489172A (en) | Acanthopanax health tea for improving immunity and preparation method thereof | |
CN104489518A (en) | Health-preserving porridge for treating neurasthenia and prepration method of health-preserving porridge | |
CN103845562A (en) | Pharmaceutical composition for treating traumatic injury | |
CN102526444A (en) | Traditional Chinese medicine composition for invigorating kidney and strengthening yang and preparation method thereof | |
CN105435197A (en) | Pharmaceutical composition for treating chronic lymphocytic thyroiditis and preparation method thereof | |
CN103977164A (en) | Traditional Chinese medicinal preparation for treating angina and preparation method | |
CN108339101A (en) | The preparation of the five internal organs function of warming yang and gore removing soft extract and the method for improving mouthfeel | |
CN107184869A (en) | A kind of pharmaceutical composition for treating gout anti-trioxypurine and preparation method thereof | |
CN104721276A (en) | Traditional Chinese medicine vinegar for treating hyperlipidemia | |
CN112089783A (en) | Application of traditional Chinese medicine composition in preparation of medicine for preventing or/and treating obesity | |
CN103705731A (en) | Traditional Chinese medicine composition for treating chronic alcoholic toxic liver disease | |
CN104206597B (en) | A kind of schisandra health care tea alleviating YIN-deficiency of the lung and kidney symptom and preparation method thereof | |
CN104644741A (en) | Traditional Chinese medicinal vinegar capable of reducing blood pressure | |
CN108743885A (en) | A kind of Chinese medicine and preparation method thereof for treating Diabetic Macrovascular Complications | |
WO2002094297A1 (en) | Herbal composition for the treatment of drug addiction and insomnia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
DD01 | Delivery of document by public notice |
Addressee: Zeng Zheng Document name: the First Notification of an Office Action |
|
DD01 | Delivery of document by public notice | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150624 |
|
WD01 | Invention patent application deemed withdrawn after publication |